VTRS
NASDAQ · Pharmaceuticals
Viatris Inc
$17.07
-0.58 (-3.29%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+9.70%
1Y
+81.79%
YTD
+37.00%
Open$18.15
Previous Close$17.65
Day High$18.39
Day Low$16.74
52W High$18.07
52W Low$8.63
Volume—
Avg Volume9.10M
Market Cap20.84B
P/E Ratio—
EPS$-0.26
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$13.14
Above
SMA 200
$10.55
Above
RSI (14)
87.6
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+619.5% upside
Current
$17.07
$17.07
Target
$122.82
$122.82
$69.38
$122.82 avg
$167.78
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 14.50B | 15.14B | 3.47B |
| Net Income | -3,563,997,894 | -3,348,223,491 | 966.90M |
| Profit Margin | -24.6% | -23.4% | 27.9% |
| EBITDA | 32.88M | 32.61M | 1.51B |
| Free Cash Flow | — | — | 925.81M |
| Rev Growth | -4.2% | -4.2% | -2.8% |
| Debt/Equity | 0.98 | 0.98 | 0.35 |
Dividend
Dividend Yield2.70%
Annual Dividend$0.48
Payout Ratio28.5%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.35 | +1.67% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $257.21 | -0.15% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.63 | +0.23% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $25.98 | +0.64% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $76.68 | +3.07% | 12.1 | 32.02B |